Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
RPID compared with KLRA: revenue, margins and what each company keeps, and the suppliers and customers both name
RPID
Rapid Micro Biosystems, Inc.
Change
Mkt cap
Revenue
Revenue
KLRA
Kailera Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
RPID
Rapid Micro Biosystems, Inc.
vs
KLRA
Kailera Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
RPID: latest quarter is a loss; flow not drawable. KLRA: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only RPID
4
—
Computershare Trust Company, N.A
unlisted
supplier
—
National Medical Care
unlisted
supplier
—
Millipore S.A.S. (MilliporeSigma)
unlisted
customer
—
U.S. Department of Health and Human Services Biomedical Advanced Research & Development Authority
unlisted
customer
Shared
0
No shared counterparties.
Only KLRA
1
—
Hengrui
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
RPID, solid
KLRA, dashed
RPID
Rapid Micro Biosystems, Inc.
Change
0.73
· pre 0.73
· delayed
Mkt cap
$36.9M
Revenue
$8M
Q2 FY26
Revenue
$34M
FY25
KLRA
Kailera Therapeutics, Inc.
Change
12.87
· pre 12.67
· delayed
Pre-market
Oct 30 '26
delayed
Mkt cap
$1.3B
Revenue
—
Revenue
—
vs
Compare
Pre-market
Oct 30 '26
delayed
RPID
Rapid Micro Biosystems, Inc.
vs
KLRA
Kailera Therapeutics, Inc.
0.73
pre 0.73
delayed
Price
12.87
pre 12.67
delayed
$36.9M
Mkt cap
$1.3B
Q2 FY26
$8M
Revenue
—
FY25
$34M
Revenue
—
Change
Change
RPID
0.73
vs
KLRA
12.87
Pre-market
Oct 30 '26
delayed